Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | TXN | P10599 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1748487 | 1.00 | MAPT (0.39) | MAPTGPR84APPTXNALDH1A1 | |
| SCHEMBL2541308 | 0.88 | HTT (0.32) | HTT | |
| SCHEMBL29909463 | 0.88 | HTT (0.32) | HTT | |
| SCHEMBL3668782 | 0.83 | ACHE (0.39) | MAPTALDH1A1HTT | |
| SCHEMBL30013667 | 0.83 | ACHE (0.39) | MAPTALDH1A1HTT | |
| SCHEMBL2170677 | 0.81 | MAPT (0.37) | MAPTGPR84 | |
| SCHEMBL29487315 | 0.81 | HTT (0.35) | HTT | |
| SCHEMBL2724749 | 0.81 | HTT (0.35) | HTT | |
| SCHEMBL25194733 | 0.77 | HTT (0.35) | HTT | |
| SCHEMBL30504344 | 0.77 | HTT (0.35) | HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118324767-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2024-07-12 | — | — | CN | disclosed |
| CN-115362003-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2022-11-18 | — | — | CN | disclosed |
| EP-4081305-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | Carna Biosciences, Inc. (JP) | 2022-11-02 | — | — | EP | disclosed |